A look back at Pokémon Uranium, the controversial fan game that still has an audience years after its legal takedown.
Kaida BioPharma, a biotechnology company developing targeted therapies for women with hard-to-treat gynecologic cancers, today announced its executive leadership team and board. Each member brings ...
DMR-001 on track for IND or CTA submission in mid-2026, with two clinical proof-of-concept datasets expected beginning mid-2027 -- -- Strong financial position with approximately $535 million in cash ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results